What's New /
International research
International migraine research
Our pick of the latest global migraine research
Each month we take a look at what new research about migraine disease has been published. We share our top picks here.
All of our top picks are free to read and are relevant for people in Aotearoa New Zealand. We look for research from reputable journals and headache researchers and prioritise those with the highest quality study design, especially randomised-controlled studies and systematic reviews.
Please visit our New Zealand research page for our own research and migraine research happening in Aotearoa New Zealand.
We also publish regular research findings on our social media pages, so please follow us on Facebook, Instagram and LinkedIn.
- Spinal manipulations for migraine: an updated systematic review and meta-analysis of randomized clinical trials
- Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-blind, randomized, phase 3 trials
- The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region
- Migraine and cognitive dysfunction: a narrative review
- Cycling sensitivity across migraine phases: A longitudinal case-control study
- Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society
- Factors and Reasons Associated with Hesitating to Seek Care for Migraine: Results of the OVERCOME (US) Study
- Hallmarks of primary headache: Part 1 – migraine
- Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening Period
- Insights from triggers and prodromal symptoms on how migraine attacks start: The threshold hypothesis
- A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study (full text not available)
- Sumatriptan-naproxen sodium in migraine: A review
- Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action
- A monoclonal antibody to PACAP for migraine prevention
- Unravelling migraine stigma: A comprehensive review of its impact and strategies for change
- International Headache Society Global Practice Recommendations for preventive pharmacological treatment of migraine
- A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study
- A thorough investigation into the correlation between migraines and the gut microbiome: an in-depth analysis using Mendelian randomization studies
- Migraine heritability and beyond: A scoping review of twin studies
- Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) cross-sectional study
- Alice in Wonderland Syndrome (AIWS): prevalence and characteristics in adults with migraine
- Longitudinal neurofunctional changes in medication overuse headache patients after mindfulness practice in a randomized controlled trial (the MIND-CM study)
- Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for the preventive treatment of chronic migraine: A single-blind, double-dummy, randomized controlled trial
- Rizatriptan as an over‑the‑counter triptan in the treatment of migraine attacks
- Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study
- Female-selective mechanisms promoting migraine
- Should we rule out celiac disease in recurrent headache disorders? A review of the literature
- Increased screen time and its association to migraine and tension-type headache: a cross-sectional investigation among Bangladeshi students
- Is painful temporomandibular disorder a real headache for many patients?
- Yoga for migraine prevention: An ancient practice with evidence for current use
- Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
